Works matching AU Hollis, Robert L.

Results: 23

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60655-y

By:

Ewing, Ailith;
Meynert, Alison;
Silk, Ryan;
Aitken, Stuart;
Bendixsen, Devin P.;
Churchman, Michael;
Brown, Stuart L.;
Hamdan, Alhafidz;
Mattocks, Joanne;
Grimes, Graeme R.;
Ballinger, Tracy;
Hollis, Robert L.;
Simon Herrington, C.;
Thomson, John P.;
Sherwood, Kitty;
Parry, Thomas;
Esiri-Bloom, Edward;
Bartos, Clare;
Croy, Ian;
Ferguson, Michelle

Publication type:

Article

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.

Published in:

2018

By:

Hollis, Robert L.;
Meynert, Alison M.;
Churchman, Michael;
Rye, Tzyvia;
Mackean, Melanie;
Nussey, Fiona;
Arends, Mark J.;
Sims, Andrew H.;
Semple, Colin A.;
Herrington, C. Simon;
Gourley, Charlie

Publication type:

journal article

Missing From Our Veterans' Care.

Published in:

Conflict Resolution & Negotiation Journal, 2015, v. 2015, n. 3, p. 3

By:

Hollis, Robert L.

Publication type:

Article

Talking Points.

Published in:

Conflict Resolution & Negotiation Journal, 2015, v. 2015, n. 2, p. 66

By:

Hollis, Robert L.

Publication type:

Article

Missing From Our Veterans' Care.

Published in:

Conflict Resolution & Negotiation Journal, 2015, v. 2015, n. 1, p. 101

By:

Hollis, Robert L.

Publication type:

Article

Missing From Our Veterans' Care.

Published in:

Ethics & Critical Thinking Journal, 2015, v. 2015, n. 2, p. 162

By:

Hollis, Robert L.

Publication type:

Article

Missing From Our Veterans' Care.

Published in:

Business Journal for Entrepreneurs, 2017, n. 3, p. 68

By:

Hollis, Robert L.

Publication type:

Article

The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific.

Published in:

JNCI Cancer Spectrum, 2024, v. 8, n. 4, p. 1, doi. 10.1093/jncics/pkae049

By:

Porter, Joanna M;
McFarlane, Iona;
Bartos, Clare;
Churchman, Michael;
May, James;
Herrington, C Simon;
Connolly, Kathryn C;
Ryan, Neil A J;
Hollis, Robert L

Publication type:

Article

Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34627-5

By:

Hollis, Robert L.;
Thomson, John P.;
van Baal, Juliette;
Ilenkovan, Narthana;
Churchman, Michael;
van de Vijver, Koen;
Dijk, Frederike;
Meynert, Alison M.;
Bartos, Clare;
Rye, Tzyvia;
Croy, Ian;
Diana, Patricia;
van Gent, Mignon;
Creedon, Helen;
Nirsimloo, Rachel;
Lok, Christianne;
Gourley, Charlie;
Herrington, C. Simon

Publication type:

Article

Editorial: Advances toward improved understanding and treatment of uncommon ovarian cancer types and subtypes.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1519252

By:

Hollis, Robert L.;
van Gent, Mignon D. J. M.

Publication type:

Article

Ovarian carcinosarcoma is highly aggressive compared to other ovarian cancer histotypes.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1399979

By:

McFarlane, Iona;
Porter, Joanna M.;
Brownsell, Elizabeth;
Ghaoui, Nidal;
Connolly, Kathryn C.;
Herrington, C. Simon;
Hollis, Robert L.

Publication type:

Article

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1389472

By:

Taylor, Sarah J.;
Hollis, Robert L.;
Gourley, Charlie;
Herrington, C. Simon;
Langdon, Simon P.;
Arends, Mark J.

Publication type:

Article

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification.

Published in:

NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00187-y

By:

Hollis, Robert L.;
Stanley, Barbara;
Thomson, John P.;
Churchman, Michael;
Croy, Ian;
Rye, Tzyvia;
Bartos, Clare;
Nussey, Fiona;
Mackean, Melanie;
Meynert, Alison M.;
Semple, Colin A.;
Gourley, Charlie;
Herrington, C. Simon

Publication type:

Article

Infection‐driven activation of transglutaminase 2 boosts glucose uptake and hexosamine biosynthesis in epithelial cells.

Published in:

EMBO Journal, 2020, v. 39, n. 8, p. 1, doi. 10.15252/embj.2019102166

By:

Maffei, Benoit;
Laverrière, Marc;
Wu, Yongzheng;
Triboulet, Sébastien;
Perrinet, Stéphanie;
Duchateau, Magalie;
Matondo, Mariette;
Hollis, Robert L;
Gourley, Charlie;
Rupp, Jan;
Keillor, Jeffrey W;
Subtil, Agathe

Publication type:

Article

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer.

Published in:

Cancers, 2020, v. 12, n. 6, p. 1647, doi. 10.3390/cancers12061647

By:

Langdon, Simon P.;
Herrington, C. Simon;
Hollis, Robert L.;
Gourley, Charlie

Publication type:

Article

Identifying and Overcoming Mechanisms of PARP Inhibitor Resistance in Homologous Recombination Repair-Deficient and Repair-Proficient High Grade Serous Ovarian Cancer Cells.

Published in:

Cancers, 2020, v. 12, n. 6, p. 1503, doi. 10.3390/cancers12061503

By:

Gomez, Miriam K.;
Illuzzi, Giuditta;
Colomer, Carlota;
Churchman, Michael;
Hollis, Robert L.;
O'Connor, Mark J.;
Gourley, Charlie;
Leo, Elisabetta;
Melton, David W.

Publication type:

Article

Genetic and molecular changes in ovarian cancer.

Published in:

Cancer Biology & Medicine, 2016, v. 13, n. 2, p. 236, doi. 10.20892/j.issn.2095-3941.2016.0024

By:

Hollis, Robert L.;
Gourley, Charlie

Publication type:

Article

Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 2539, doi. 10.2147/OTT.S102569

By:

Hollis, Robert L.;
Churchman, Michael;
Gourley, Charlie

Publication type:

Article

High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.

Published in:

2019

By:

Hollis, Robert L.;
Churchman, Michael;
Michie, Caroline O.;
Rye, Tzyvia;
Knight, Laura;
McCavigan, Andrena;
Perren, Timothy;
Williams, Alistair R. W.;
McCluggage, W. Glenn;
Kaplan, Richard S.;
Jayson, Gordon C.;
Oza, Amit;
Harkin, D. Paul;
Herrington, C. Simon;
Kennedy, Richard;
Gourley, Charlie

Publication type:

journal article

Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.

Published in:

British Journal of Cancer, 2024, v. 130, n. 2, p. 327, doi. 10.1038/s41416-023-02508-3

By:

Herrington, C. Simon;
Oswald, Ailsa J.;
Stillie, Lorna J.;
Croy, Ian;
Churchman, Michael;
Hollis, Robert L.

Publication type:

Article

Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma.

Published in:

2022

By:

Hollis, Robert L.;
Croy, Ian;
Churchman, Michael;
Bartos, Clare;
Rye, Tzyvia;
Gourley, Charlie;
Herrington, C. Simon

Publication type:

journal article

Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma.

Published in:

Cancers, 2021, v. 13, n. 22, p. 5839, doi. 10.3390/cancers13225839

By:

Hollis, Robert L.;
Stillie, Lorna J.;
Hopkins, Samantha;
Bartos, Clare;
Churchman, Michael;
Rye, Tzyvia;
Nussey, Fiona;
Fegan, Scott;
Nirsimloo, Rachel;
Inman, Gareth J.;
Herrington, C. Simon;
Gourley, Charlie

Publication type:

Article

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.

Published in:

Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18819-5

By:

Hollis, Robert L.;
Thomson, John P.;
Stanley, Barbara;
Churchman, Michael;
Meynert, Alison M.;
Rye, Tzyvia;
Bartos, Clare;
Iida, Yasushi;
Croy, Ian;
Mackean, Melanie;
Nussey, Fiona;
Okamoto, Aikou;
Semple, Colin A.;
Gourley, Charlie;
Herrington, C. Simon

Publication type:

Article